¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"blood disorder"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • delusional disorder
    ¸Á»óÀå¾Ö
  • demyelinating disorder
    ¸»ÀÌÁýÅ»¶ôÁúȯ, Å»¼öÃÊÁúȯ
  • dependent personality disorder
    ÀÇÁ¸ÀΰÝÀå¾Ö
  • depersonalization disorder
    ÀÌÀÎ(ìÆìÑ)Àå¾Ö
  • depressive disorder
    ¿ì¿ïÀå¾Ö
  • developmental disorder
    ¹ß´ÞÀå¾Ö
  • developmental receptive language disorder
    ¹ß´Þ¼ö¿ë¾ð¾îÀå¾Ö
  • disorder
    1. Àå¾Ö 2. º´ 3. Áúȯ
  • dissociative disorder
    ÇØ¸®Àå¾Ö
  • dissociative identity disorder
    ÇØ¸®Á¤Ã¼¼ºÀå¾Ö
  • extrapyramidal disorder
    ÇǶó¹Ìµå¹Ù±ù±æÀå¾Ö, Ãßü¿Ü·ÎÀå¾Ö
  • eating disorder
    ½Ä»çÀå¾Ö
  • female sexual arousal disorder
    ¿©¼º¼º(Àû)ÈïºÐÀå¾Ö
  • factitious disorder
    ÀÎÀ§Àå¾Ö
  • functional disorder
    ±â´É¼ºÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • cyclothymic disorder
    ¼øÈ¯¼º±âºÐÀå¾Ö
  • disorder
    Àå¾Ö, Áúȯ
  • delusional disorder
    ¸Á»óÀå¾Ö
  • demyelinating disorder
    ¸»ÀÌÁýÅ»¶ôÁúȯ
  • dependent personality disorder
    ÀÇÁ¸ÀΰÝÀå¾Ö
  • depersonalization disorder
    ÀÌÀÎÀå¾Ö
  • depressive disorder
    ¿ì¿ïÀå¾Ö
  • developmental disorder
    ¹ß´ÞÀå¾Ö
  • developmental receptive language disorder
    ¹ß´Þ¼ö¿ë¾ð¾îÀå¾Ö
  • dissociative disorder
    ÇØ¸®Àå¾Ö, ÇØ¸®º´
  • dysthymic disorder
    ±âºÐÀúÇϺ´, ±âºÐÀúÇÏÀå¾Ö
  • eating disorder
    ¸Ô±âÀå¾Ö, ¸Ô±âº´
  • electrolyte disorder
    ÀüÇØÁúÀå¾Ö
  • extrapyramidal disorder
    Ãßü¿Ü·ÎÀå¾Ö
  • factitious disorder
    ÀÎÀ§ÀûÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • psychosomatic disorder
    Á¤½Å½ÅüÀå¾Ö(º´)
  • psychotic disorder
    Á¤½ÅÁõÀû Àå¾Ö(º´)
  • reactive attachment disorder
    ¹ÝÀÀ¼º ¾ÖÂø(äñó·)Àå¾Ö(º´)
  • recurrent brief depressive disorder
    Àç¹ß¼º ´Ü±â¿ì¿ïÀå¾Ö(º´)
  • renal disorder
    ½ÅÀå¾Ö(ãìî¡äô).
  • renal disorder
    ½ÅÀå¾Ö(ãìî¡äô)
  • renal vascular disorder
    ½ÅÇ÷°üÁúȯ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • neurological disorder
    ½Å°æ°èÀå¾Ö.
  • neuromuscular disorder
    ½Å°æ±ÙÀ°Áúȯ
  • neuromuscular disorder
    ½Å°æ±ÙÁúȯ(~òðü´).
  • neuroskeletal disorder
  • neurotic disorder
  • neurovascular disorder
    ½Å°æÇ÷°üÀå¾Ö(~î¡äô).
  • obsessive compulsive disorder=OCD
  • obsessive compulsive personality disorder
  • obssesive-compulsive disorder
  • occupational disorder
    Á÷¾÷¼º Áúȯ
  • opioid use disorder
    ¾ÆÆí¾çÁ¦Á¦ »ç¿ëÀå¾Ö(º´).
  • opioid-induced disorder
    ¾ÆÆí¾çÁ¦Á¦ À¯µµ¼ºÀå¾Ö(ë¯Óôàõî¡äô)(º´)
  • opioid-related disorder
    ¾ÆÆí¾çÁ¦Á¦ °ü·ÃÀå¾Ö(μ֤î¡äô)(º´)
  • oppositional defiant disorder
    ¹ÝÇ×¼º µµÀüÀå¾Ö(º´), Àû´ëÀû ¹ÝÇ×¹æ¾Ö(º´)
  • oppositional disorder
    ¹ÝÇ×Àå¾Ö(º´)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
ADCC acute disorder of cerebral circulation; antibody-dependent cell-mediated cytotoxicity
ADD acceptable daily dose; adduction; adenosine deaminase; attentional deficit disorder; average daily d...
ADDH attention deficit disorder with hyperactivity
ADD/HA attention deficit disorder/hyperactivity
ADHD attention deficit-hyperactivity disorder
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
SAD SEASONAL AFFECTIVE DISORDER
SADS Schedule for Affective Disorder and Schizophrenia
SPD Schizotypal Personality Disorder
SD Somatization disorder
TDI Thought Disorder Index
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • functional mandibular disorder
    ±â´ÉÀû ÇÏ¾Ç Àå¾Ö
    ºñÁ¤»óÀûÀÎ ÇÏ¾Ç ¿îµ¿À̳ª ÀÛ¿ë°ú °ü·ÃµÈ Àå¾Ö.
  • habit and impulse disorder
    ½À°ü ¹× Ãæµ¿ Àå¾Ö, ½À°ü ¹× Ãæµ¿º´
  • headache disorder
    µÎÅë Àå¾Ö
  • hemologic disorder
    Ç÷¾× Àå¾Ö
  • hemolytic disorder
    ¿ëÇ÷¼º Áúȯ
  • hemorrhagic disorder
    ÃâÇ÷ Àå¾Ö
    ÁöÇ÷À» ¹æÇØÇÏ´Â ¿ä¼Ò¸¦ °¡Áø º´.
  • iatrogenic disorder
    ÀǼº Àå¾Ö, ÀÇ¿ø¼º Àå¾Ö
  • identity disorder
    ÁÖü¼º Àå¾Ö
    Á÷¾÷ ¼±Á¤, ¼ºÀû Áö³²·Â, Çൿ, µµ´öÀû °¡Ä¡°ü µî¿¡ ´ëÇÑ ºÒÈ®½Å°ú ÇÔ²², ÀÚ±âÀÚ½ÅÀÇ ±¹¸éÀ» ºñ±³Àû ÀϰüµÈ Àüü¿¡ ÀÏÄ¡½ÃŰÁö ¸øÇϰí ÀÚ½ÅÀÇ ÀνÄÀ» ¼ö¿ëÇÏÁö ¸øÇÏ´Â °Í¿¡ ´ëÇÑ ½ÉÇÑ ÁÖ°üÀû °í³ú·Î, 3°³¿ù ȤÀº ±× ÀÌ»ó Áö¼ÓµÇ¸ç, »çÃá±â Èıâ û¼Ò³â¿¡ °¡Àå ÈçÈ÷ ³ªÅ¸³­´Ù.
  • induced psychotic disorder
    À¯µµµÈ Á¤½Åº´Àû Àå¾Ö
    ÇöÀúÇÑ ¸Á»óÀ¸·Î ÀÌ¹Ì Á¤½Åº´Àû Àå¾Ö¸¦ °¡Áø ¾î¶² »ç¶÷°ú Ä£±ÙÇÑ °ü°è¸¦ °¡Áø °á°ú·Î, ´ÙÀ½ »ç¶÷¿¡°Ôµµ »ý±ä ¸Á»óü°è.
  • inflammatory disorder
    ¿°Áõ¼º Àå¾Ö
  • inflammatory joint disorder
    ¿°Áõ¼º °üÀý Àå¾Ö
  • intermittent explosive disorder
    °£ÇæÀû Æø¹ß¼º Àå¾Ö
    °£ÇæÀûÀ¸·Î ¿©·¯ ¹ø °ø°Ý¼º Ãæµ¿ÀÇ Á¶Á¤À» »ó½ÇÇÏ¿© ±× »ç¶÷ÀÇ Á¤»óÀû Àΰݿ¡ ¸ÂÁö ¾Ê´Â ½ÉÇÑ ÆøÇàÀ̳ª ±â¹° ÆÄ±«¸¦ ÃÊ·¡ÇÏ´Â °ÍÀÌ Æ¯Â¡ÀÎ ±â´ÉÀû Á¤½Å Àå¾ÖÀÇ ÀÏÁ¾. Àü¿¡´Â Æø¹ß¼º ÀÎ°Ý ¶Ç´Â °£ÁúÇü ÀÎ°Ý Àå¾Ö¶ó°í ĪÇߴµ¥, °£ÇæÀû ÇൿÀÌ ÀÎ°Ý Æ¯¼ºÀÌ µÉ ¼ö ¾øÀ¸¹Ç·Î À߸øµÈ ȣĪÀÌ´Ù.
  • intracapsular disorder
    °üÀý³¶³» Àå¾Ö
  • joint disorder
    °üÀý Àå¾Ö
  • language disorder
    ¾ð¾î Àå¾Ö
    ¸»À» ¹Ù¸£°Ô ¹ßÀ½ÇÏÁö ¸øÇϰųª Á¤È®ÇÏ°Ô ÀÌÇØÇÏÁö ¸øÇÏ´Â »óÅÂ. Àΰ£Àº ¸»
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
blood plastid Any basic, morphologic unit in the biologic composition of blood, e.g., an erythrocyte.
(05 Mar 2000)
blood platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation.
(12 Dec 1998)
blood poisoning See: septicaemia, pyaemia.
(05 Mar 2000)
blood pool imaging Nuclear medicine study using a radionuclide that is confined to the vascular compartment.
(05 Mar 2000)
blood porphyrin level A test which is used to measure red blood cell porphyrin levels. Porphyrins are pigments found in both animal and plant life.
This test is useful in evaluating any number of porphyrin disorders (involving the various porphyrins) of red blood cells.
Increased levels of coproporphyrins can indicate congenital erythropoietic porphyria or sideroblastic anaemia.
Increased protoporphyrins may be seen in infection, thalassaemia, sideroblastic anaemia, iron deficient anaemia, increased erythropoiesis and lead poisoning. Increased uroporphyrins may indicate congenital erythropoietic porphyria or erythropoietic protoporphyria.
(27 Sep 1997)
blood pressure <cardiology, physiology> The force that the circulating blood exerts on the walls of the arteries.
This measurement is divided into systolic (pressure during contraction of the heart) and diastolic (pressure during relaxation phase).
Blood pressure varies with age and sex of the individual. A rough rule of thumb for normal systolic pressure is 100 + Age of individual. In children 2 x (age) + 80 = systolic BP The diastolic pressure should be roughly 2/3 the systolic pressure.
(27 Sep 1997)
blood pressure determination Techniques for measuring blood pressure.
(12 Dec 1998)
blood pressure, high High blood pressure (hypertension) is a repeatedly elevated blood pressure exceeding 140 over 90 mmHg. High blood pressure is also called the silent killer. Chronically high blood pressure can cause blood vessel changes in the back of the eye (retina), thickening of the heart muscle, kidney failure, and brain damage. No specific cause for high blood pressure is found in 95% of patients. High blood pressure is treated with salt restriction, regular aerobic exercise, and medications.
(12 Dec 1998)
blood pressure monitoring, ambulatory Method in which prolonged blood pressure readings are made while the patient undergoes normal daily activities. It allows quantitative analysis of the high blood pressure load over time, can help distinguish between types of hypertension, and can assess the effectiveness of antihypertensive therapy.
(12 Dec 1998)
blood pressure monitors Devices for continuously measuring and displaying the arterial blood pressure.
(12 Dec 1998)
blood products Biopharmaceutical products purified from human blood, such as the blood clotting factor VIII used to treat haemophiliacs. (Recombinant factor VIII is also on the market.) The term also refers to biopharmaceuticals that act on blood or the cells that make blood. These products are often produced by the cells themselves, but in such tiny amounts that extracting them from blood is impractical, and so they are genetically engineered.
(14 Nov 1997)
blood protein electrophoresis Electrophoresis applied to blood proteins.
(12 Dec 1998)
blood proteins The hundreds of different proteins present in blood plasma, including carrier proteins (such as serum albumin, transferrin, and haptoglobins), fibrinogen and other blood coagulation factors, complement components, immunoglobulins, enzyme inhibitors, precursors of substances such as the angiotensins and bradykinin, and many other types of proteins.
(12 Dec 1998)
blood puzzles Foreign bodies or deformed blood cells that may be misinterpreted as infectious agents (e.g., bacteria, fungi) in stained films as a result of similarities in morphology and staining properties.
(05 Mar 2000)
blood relationship A relationship that share a common bloodline, descent from a common ancestor.
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á